Divergent Capital 7651

Articles

14

Companies covered

11

Sectors

2

Countries

2

Research Articles

Q1'26 Idea Inventory, Part 1: $CPH.TO, $RCI.B, $SNAP, $HON.

Feb 18, 2026

Allison Transmission (ALSN) & Dana Inc (DAN) Merger: A Merger Opportunity with Low Deal Risk

Nov 24, 2025

GCI Liberty: A Spin-Off Opportunity with Multiple Catalysts

Jul 11, 2025

Notes from Cipher Pharmaceuticals' Planet Microcap Interview dated 21 August 2024.

Aug 22, 2024

Estimate of Cipher Pharmaceuticals' Potential Future Operating Income Post-Natroba Acquisition.

Aug 12, 2024

Initial Thoughts on Cipher's Acquisition of ParaPRO's, "Natroba"

Aug 1, 2024

Haypp Group AB: A Fly-Wheel Business Surfing the Nicotine Pouch Tidal Wave, Positioned to Thrive Amidst Intense Competition

Jul 9, 2024

Haypp Group AB: Write-Up Preview

Jul 4, 2024

BQE Water: A Capital-Light Compounder with Expanding Margins and Long-Term Recurring Revenues

Jun 1, 2024

BQE Water: Write-Up Preview

May 30, 2024

Moberg Pharma AB: A Royalty on an Innovative Treatment for a Condition Affecting Hundreds of Millions of People Globally

May 24, 2024

Cipher Pharmaceuticals: A High ROIC Legacy Business at a Fair Price with a Free Call-Option on Two Unpriced Catalysts

May 19, 2024

Cipher Pharmaceuticals: Write-Up Preview

May 13, 2024

Moberg Pharma AB: Write-Up Preview

May 9, 2024